Analyst Ratings for Biogen (BIIB)
BIIB Rating Summary
BIIB Price Target Summary
- Highest: $425.00 (JPMorgan)
- Lowest: $185.00 (Wedbush)
- Average: $265.92
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$265.92 (+25.5%)
* Over Last 12-Mos
Rating Score: 4.8 / 10
Percentile Rank: 44%
Rating Score: 4.8 / 10

Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
4/18/2022 | Wells Fargo | Mohit Bansal | Upgrade | Overweight (Equal Weight) |
265.00 (N/A) |
212.55 (211.93) |
-0.29% | Details |
3/8/2022 | Stifel » Updated 5/3/2022 |
Paul Matteis | Downgrade | Hold (Buy) |
230.00 (N/A) |
209.45 (211.93) |
1.18% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |